IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMILLONI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.386
AS - Asia 3.428
EU - Europa 2.877
SA - Sud America 602
Continente sconosciuto - Info sul continente non disponibili 282
AF - Africa 76
OC - Oceania 8
Totale 12.659
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.163
SG - Singapore 1.501
IE - Irlanda 523
BR - Brasile 468
VN - Vietnam 468
HK - Hong Kong 458
IT - Italia 442
UA - Ucraina 437
CN - Cina 431
RU - Federazione Russa 411
DE - Germania 252
FR - Francia 188
FI - Finlandia 183
KR - Corea 120
SE - Svezia 118
GB - Regno Unito 108
CA - Canada 107
BD - Bangladesh 99
IN - India 76
TR - Turchia 56
AR - Argentina 40
MX - Messico 40
AT - Austria 33
PL - Polonia 28
PK - Pakistan 27
EC - Ecuador 25
NL - Olanda 24
BE - Belgio 23
SA - Arabia Saudita 23
ID - Indonesia 21
IQ - Iraq 21
CO - Colombia 20
CH - Svizzera 19
JP - Giappone 18
CR - Costa Rica 16
UZ - Uzbekistan 16
ZA - Sudafrica 16
LB - Libano 15
ES - Italia 14
PH - Filippine 14
MA - Marocco 13
PT - Portogallo 13
VE - Venezuela 13
CZ - Repubblica Ceca 11
PY - Paraguay 11
CL - Cile 10
HN - Honduras 9
IL - Israele 9
LT - Lituania 9
GR - Grecia 8
MY - Malesia 8
GT - Guatemala 7
AU - Australia 6
AZ - Azerbaigian 6
CW - ???statistics.table.value.countryCode.CW??? 6
KE - Kenya 6
OM - Oman 6
PE - Perù 6
RO - Romania 6
SV - El Salvador 6
TN - Tunisia 6
BG - Bulgaria 5
BO - Bolivia 5
EE - Estonia 5
EG - Egitto 5
GP - Guadalupe 5
JM - Giamaica 5
JO - Giordania 5
PR - Porto Rico 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
GH - Ghana 4
NP - Nepal 4
SC - Seychelles 4
TH - Thailandia 4
BB - Barbados 3
EU - Europa 3
PA - Panama 3
PS - Palestinian Territory 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
DK - Danimarca 2
ET - Etiopia 2
KG - Kirghizistan 2
KH - Cambogia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 12.353
Salva come PNG Salva come JPEG
Città #
Singapore 1.099
Ashburn 713
Chandler 542
Dublin 522
San Jose 494
Hong Kong 457
Dong Ket 290
Jacksonville 241
San Mateo 240
Santa Clara 206
Council Bluffs 176
Boardman 166
Moscow 158
Lauterbourg 124
Princeton 119
Medford 115
Beijing 111
Munich 108
Seoul 104
Perugia 102
Wilmington 82
Los Angeles 76
Ho Chi Minh City 74
New York 74
Andover 73
Ann Arbor 72
São Paulo 68
Helsinki 56
Piscataway 40
Altamura 38
Rome 37
Orem 34
Izmir 33
Lawrence 32
Columbus 31
Turku 31
Montreal 29
The Dalles 29
Dallas 28
Saint Petersburg 28
Hanoi 27
Brooklyn 26
Des Moines 25
Toronto 25
Chicago 24
Genoa 23
London 23
Houston 22
North Bergen 22
Falls Church 21
Norwalk 21
Nuremberg 21
Ottawa 20
Vienna 19
Frankfurt am Main 18
Phoenix 18
Redwood City 18
Warsaw 18
Buffalo 17
Denver 17
Redmond 17
Boston 16
Chennai 16
Amsterdam 15
Atlanta 15
Florence 15
Tokyo 15
Dongjak-gu 14
Mexico City 14
Milan 14
Brussels 13
Johannesburg 12
San José 12
Hefei 11
Mumbai 11
Rio de Janeiro 11
Seattle 11
Belo Horizonte 10
Charlotte 10
Riyadh 10
Stockholm 10
Terni 10
Woodbridge 10
Ankara 9
Bogotá 9
Bologna 9
Curitiba 9
Da Nang 9
Manchester 9
Naples 9
Philadelphia 9
Shanghai 9
Haiphong 8
Jakarta 8
San Francisco 8
Baghdad 7
Falconara Marittima 7
Guarulhos 7
Guatemala City 7
Karachi 7
Totale 7.909
Salva come PNG Salva come JPEG
Nome #
10-Year Rotavirus Infection Surveillance: Epidemiological Trends in the Pediatric Population of Perugia Province 213
Antibodies cross-reactive to seasonal influenza A(H1N1)pdm09 viruses in human sera of elderly people immunized with trivalent influenza vaccines containing the A/California/7/09 vaccine strain 156
Accelerate Pheno™ blood culture detection system: a literature review 156
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 154
Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial 154
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis 153
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 134
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 133
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 131
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 131
Influenza vaccination in patients on long-term anticoagulant therapy 130
Influenza vaccination in patients on long-term anticoagulant therapy. 128
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 128
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 126
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 125
Annually repeated influenza vaccination and humoral response in elderly volunteers. 124
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 124
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 123
Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine 120
A novel methodology based on serological data for improving precision in the influenza vaccine response of non-seroprotected 120
An influenza outbreak in elderly vaccinated people in the winter season 2007/2008 118
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 118
A G12P[8] rotavirus gastroenteritis outbreak in Italy, 2013 117
UN MAGGIORE UTILIZZO DI SIERI UMANI PUO’ CONTRIBUIRE AD UNA MIGLIORE CARATTERIZZAZIONE ANTIGENICA DEI VIRUS INFLUENZALI PER LA SCELTA DELLE COMPONENTI VACCINALI 117
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 117
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 116
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 115
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 115
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 113
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 113
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 112
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 110
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 110
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages 110
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 110
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 110
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 108
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 108
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 107
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 106
The effect of influenza vaccination in patients on long-term oral anticoagulant therapy 105
Twenty-seven years experience with immunogenicity of inactivated influenza vaccines in the elderly 103
Drugs for Influenza Treatment: Is There Significant News? 102
Hospital‐acquired rotavirus acute gastroenteritis in 10 consecutive seasons in Umbria (Italy) 101
L’influenza in Umbria nell’inverno 2005/06 100
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 99
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 99
First detection of a reassortant G3P[8] rotavirus Astrain in Italy: a case report in an 8-year-old child 99
Group a rotavirus surveillance before vaccine introduction in italy, september 2014 to august 2017 98
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 98
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 98
Multiplex platforms for the identification of respiratory pathogens: Are they useful in pediatric clinical practice? 98
Co-circulation of SARS-CoV-2 Alpha and Gamma variants in Italy, February and March 2021 98
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 98
Cross-reactive antibodies to viruses of both B/Victoria and B/Yamagata lineages as induced by influenza vaccination in middle-aged and elderly volunteers 96
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 96
Vaccination against paediatric respiratory pathogens 96
SARS-CoV-2 in semen: a multicenter prospective study and literature review 95
Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance 95
Declined antibody response following influenza vaccination in elderly as compared with middle-aged volunteers: effects of aging and/or original antigenic sin? 95
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 94
Serological methods are able to determine how well influenza vaccines work 94
Induzione di anticorpi omologhi e cross-reattivi nei confronti di virus influenzali di tipo B da parte del vaccino influenzale nell'inverno 2003/2004 93
Immunization with adjuvanted and non-adjuvanted influenza vaccines of HIV-1 positive patients treated with highly active antiretroviral therapy (HAART) 93
Pandemic Influenza A/H1N1pdm in Italy: Age, Risk and Population Susceptibility 93
Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection 92
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 92
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 90
Serologically diagnosed influenza virus A/California/7/04 (H3N2)infection in people immunised with A/Fujan/411/2002(H3N2)antigen during the 2004/05 winter season 89
Monitoring of indoor bioaerosol for the detection of SARS-CoV-2 in different hospital settings 88
Flow cytometric analysis of intracellular antigen-specific interferon-gamma in human NK and T populations after influenza vaccination 88
Effect of age on serum heterologous antibody response elicited by inactivated influenza virus vaccine 88
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 86
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 86
Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022 86
Case report: Coxiella burnetii endocarditis in the absence of evident exposure 84
Increased immunogenicity of an adjuvanted influenza vaccine compared with a conventional subunit vaccine in non-elderly adult HIV seropositive individuals, treated with HAART 84
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 84
null 83
Uncommon G9P[4] group A rotavirus strains causing dehydrating diarrhea in young children in Italy 82
Detection of Unusual G6 Rotavirus Strains in Italian Children With Diarrhoea During the 2011 Surveillance Season 81
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 81
Design and validation of a self-administered questionnaire to assess knowledge, attitudes and behaviours about Zika virus infection among general population in Italy. A pilot study conducted among Italian residents in public health 80
Hospital discharges-based search of acute flaccid paralysis cases 2007-2016 in Italy and comparison with the National Surveillance System for monitoring the risk of polio reintroduction 78
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 78
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 78
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 77
Efficacy of an inactivated influenza vaccine among well immunized nursing home residents during the 2007/2008 season 76
Factors influencing humoral immune response after influenza vaccination in elderly and very elderly subjects 76
Circulation and Seasonality of Respiratory Viruses in Hospitalized Patients during Five Consecutive Years (2019-2023) in Perugia, Italy 75
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age 75
Immunogenicità ed efficacia protettiva del vaccino influenzale per l’inverno 2007/08 in soggetti residenti in casa di riposo 75
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 75
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 75
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 75
Unexpected spreading of G12P[8] rotavirus strains among young children in a small area of central Italy 75
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 75
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 75
Measles immunity in healthcare workers of an Italian hospital 75
L'influenza: sistemi di sorveglianza e campagne vaccinali 73
Totale 10.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.457
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022650 0 0 0 21 31 16 7 308 15 14 103 135
2022/20231.622 119 176 14 144 125 181 3 83 694 5 54 24
2023/2024766 70 67 40 15 7 4 183 33 114 20 121 92
2024/20251.964 25 195 58 87 308 91 97 86 361 142 317 197
2025/20264.097 258 256 217 509 531 382 710 219 466 332 157 60
2026/20271.503 71 116 302 1.014 0 0 0 0 0 0 0 0
Totale 12.659